U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Hindgut Neuroendocrine Tumor G1

MedGen UID:
232290
•Concept ID:
C1334029
•
Neoplastic Process
Synonym: Hindgut Carcinoid Tumor

Definition

A neuroendocrine tumor grade 1 that arises from the sigmoid colon, descending colon, or rectum. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVHindgut Neuroendocrine Tumor G1

Professional guidelines

PubMed

A retrospective review of diagnosis and treatment modalities of neuroendocrine tumors (excluding primary lung cancer) in 10 oncological institutions of the East German Study Group of Hematology and Oncology (OSHO), 2010-2012.
Maschmeyer G, Mügge LO, Kämpfe D, Kreibich U, Wilhelm S, Aßmann M, Schwarz M, Kahl C, Köhler S, Grobe N, Niederwieser D
J Cancer Res Clin Oncol 2015 Sep;141(9):1639-44. Epub 2015 Mar 15 doi: 10.1007/s00432-015-1954-x. PMID: 25773126

Recent clinical studies

Etiology

Clinical outcomes of patients with G1/G2 neuroendocrine tumors arising from foregut or hindgut treated with somatostatin analogs: a retrospective study.
Ida H, Honma Y, Hirano H, Shoji H, Iwasa S, Okita N, Takashima A, Kato K, Fukuda T, Boku N
Invest New Drugs 2019 Jun;37(3):573-578. Epub 2018 Sep 28 doi: 10.1007/s10637-018-0669-7. PMID: 30267338
The clinicopathological significance of angiogenesis in hindgut neuroendocrine tumors obtained via an endoscopic procedure.
Okubo Y, Motohashi O, Nakayama N, Nishimura K, Kasajima R, Miyagi Y, Shiozawa M, Yoshioka E, Suzuki M, Washimi K, Kawachi K, Nito M, Kameda Y, Yokose T
Diagn Pathol 2016 Nov 8;11(1):128. doi: 10.1186/s13000-016-0580-5. PMID: 27821179Free PMC Article
A retrospective review of diagnosis and treatment modalities of neuroendocrine tumors (excluding primary lung cancer) in 10 oncological institutions of the East German Study Group of Hematology and Oncology (OSHO), 2010-2012.
Maschmeyer G, Mügge LO, Kämpfe D, Kreibich U, Wilhelm S, Aßmann M, Schwarz M, Kahl C, Köhler S, Grobe N, Niederwieser D
J Cancer Res Clin Oncol 2015 Sep;141(9):1639-44. Epub 2015 Mar 15 doi: 10.1007/s00432-015-1954-x. PMID: 25773126

Diagnosis

IMP3 Immunohistochemical Expression Remains Consistent Among All Grades of Gastrointestinal Neuroendocrine Tumors.
Agostini-Vulaj D, Whitney-Miller CL, Gonzalez RS, McMahon LA, Findeis-Hosey JJ
Appl Immunohistochem Mol Morphol 2018 Apr;26(4):288-293. doi: 10.1097/PAI.0000000000000416. PMID: 27438513
A retrospective review of diagnosis and treatment modalities of neuroendocrine tumors (excluding primary lung cancer) in 10 oncological institutions of the East German Study Group of Hematology and Oncology (OSHO), 2010-2012.
Maschmeyer G, Mügge LO, Kämpfe D, Kreibich U, Wilhelm S, Aßmann M, Schwarz M, Kahl C, Köhler S, Grobe N, Niederwieser D
J Cancer Res Clin Oncol 2015 Sep;141(9):1639-44. Epub 2015 Mar 15 doi: 10.1007/s00432-015-1954-x. PMID: 25773126

Therapy

Clinical outcomes of patients with G1/G2 neuroendocrine tumors arising from foregut or hindgut treated with somatostatin analogs: a retrospective study.
Ida H, Honma Y, Hirano H, Shoji H, Iwasa S, Okita N, Takashima A, Kato K, Fukuda T, Boku N
Invest New Drugs 2019 Jun;37(3):573-578. Epub 2018 Sep 28 doi: 10.1007/s10637-018-0669-7. PMID: 30267338
Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors.
Ito T, Honma Y, Hijioka S, Kudo A, Fukutomi A, Nozaki A, Kimura Y, Motoi F, Isayama H, Komoto I, Hisamatsu S, Nakajima A, Shimatsu A
Invest New Drugs 2017 Aug;35(4):499-508. Epub 2017 May 3 doi: 10.1007/s10637-017-0466-8. PMID: 28470558Free PMC Article

Prognosis

Clinical outcomes of patients with G1/G2 neuroendocrine tumors arising from foregut or hindgut treated with somatostatin analogs: a retrospective study.
Ida H, Honma Y, Hirano H, Shoji H, Iwasa S, Okita N, Takashima A, Kato K, Fukuda T, Boku N
Invest New Drugs 2019 Jun;37(3):573-578. Epub 2018 Sep 28 doi: 10.1007/s10637-018-0669-7. PMID: 30267338
The clinicopathological significance of angiogenesis in hindgut neuroendocrine tumors obtained via an endoscopic procedure.
Okubo Y, Motohashi O, Nakayama N, Nishimura K, Kasajima R, Miyagi Y, Shiozawa M, Yoshioka E, Suzuki M, Washimi K, Kawachi K, Nito M, Kameda Y, Yokose T
Diagn Pathol 2016 Nov 8;11(1):128. doi: 10.1186/s13000-016-0580-5. PMID: 27821179Free PMC Article

Clinical prediction guides

Clinical outcomes of patients with G1/G2 neuroendocrine tumors arising from foregut or hindgut treated with somatostatin analogs: a retrospective study.
Ida H, Honma Y, Hirano H, Shoji H, Iwasa S, Okita N, Takashima A, Kato K, Fukuda T, Boku N
Invest New Drugs 2019 Jun;37(3):573-578. Epub 2018 Sep 28 doi: 10.1007/s10637-018-0669-7. PMID: 30267338
The clinicopathological significance of angiogenesis in hindgut neuroendocrine tumors obtained via an endoscopic procedure.
Okubo Y, Motohashi O, Nakayama N, Nishimura K, Kasajima R, Miyagi Y, Shiozawa M, Yoshioka E, Suzuki M, Washimi K, Kawachi K, Nito M, Kameda Y, Yokose T
Diagn Pathol 2016 Nov 8;11(1):128. doi: 10.1186/s13000-016-0580-5. PMID: 27821179Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...